We just received data on a new analyst forecast for $NTRA. Piper Sandler gave a rating of 'Overweight' for $NTRA.
$NTRA Analyst Ratings
Wall Street analysts have issued reports on $NTRA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 05/15/2025
- Bernstein issued a "Outperform" rating on 01/10/2025
To track analyst ratings and price targets for $NTRA, check out Quiver Quantitative's $NTRA forecast page.
$NTRA Congressional Stock Trading
Members of Congress have traded $NTRA stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 11/20.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$NTRA Insider Trading Activity
$NTRA insiders have traded $NTRA stock on the open market 231 times in the past 6 months. Of those trades, 0 have been purchases and 231 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by insiders over the last 6 months:
- MATTHEW RABINOWITZ (EXECUTIVE CHAIRMAN) has made 0 purchases and 21 sales selling 222,848 shares for an estimated $35,991,123.
- STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT) has made 0 purchases and 25 sales selling 226,520 shares for an estimated $34,513,023.
- MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 32 sales selling 90,125 shares for an estimated $15,231,949.
- ROELOF BOTHA has made 0 purchases and 5 sales selling 87,473 shares for an estimated $14,793,563.
- SOLOMON MOSHKEVICH (PRESIDENT, CLINICALDIAGNOSTICS) has made 0 purchases and 26 sales selling 54,508 shares for an estimated $8,711,008.
- DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER) has made 0 purchases and 13 sales selling 37,830 shares for an estimated $6,219,834.
- JONATHAN SHEENA has made 0 purchases and 77 sales selling 37,834 shares for an estimated $5,869,858.
- JOHN FESKO (PRESIDENT, CHIEF BUS. OFFICER) has made 0 purchases and 13 sales selling 29,437 shares for an estimated $4,821,095.
- GAIL BOXER MARCUS has made 0 purchases and 18 sales selling 21,682 shares for an estimated $3,309,237.
- ROWAN E CHAPMAN sold 1,767 shares for an estimated $300,808
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NTRA Hedge Fund Activity
We have seen 344 institutional investors add shares of $NTRA stock to their portfolio, and 326 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,795,315 shares (+56.3%) to their portfolio in Q1 2025, for an estimated $536,695,494
- BLACKROCK, INC. added 1,260,125 shares (+13.7%) to their portfolio in Q1 2025, for an estimated $178,194,276
- KYNAM CAPITAL MANAGEMENT, LP removed 854,528 shares (-42.3%) from their portfolio in Q1 2025, for an estimated $120,838,804
- GOLDMAN SACHS GROUP INC removed 734,551 shares (-43.3%) from their portfolio in Q1 2025, for an estimated $103,872,856
- CITADEL ADVISORS LLC added 691,990 shares (+48.4%) to their portfolio in Q1 2025, for an estimated $97,854,305
- JPMORGAN CHASE & CO added 660,538 shares (+9.9%) to their portfolio in Q1 2025, for an estimated $93,406,678
- D. E. SHAW & CO., INC. removed 563,235 shares (-69.9%) from their portfolio in Q1 2025, for an estimated $79,647,061
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
